OneOdio Concludes a Successful IFA 2026 Showcase in Berlin
12-09-2026 14:00 via prnewswire.com

OneOdio Concludes a Successful IFA 2026 Showcase in Berlin

BERLIN, Sept. 12, 2026 /PRNewswire/ -- OneOdio concluded its showcase at IFA 2026, held from September 4–8 in Berlin. At Hall 8.2, Booth 217, the professional audio brand welcomed visitors, DJs, creators, and industry professionals for hands-on product experiences, live DJ performances,...
Read more »

PR Public relations news



Capricor Deadline: CAPR Investors Have Opportunity to Lead Capricor Therapeutics, Inc. Securities Fraud Lawsuit
Capricor Deadline: CAPR Investors Have Opportunity to Lead Capricor Therapeutics, Inc. Securities Fraud Lawsuit
PANDAG G1 to Make First Official Appearance at GaLaBau 2026
PANDAG G1 to Make First Official Appearance at GaLaBau 2026
Everlight Wins 2026 Madison People's Choice Award
Everlight Wins 2026 Madison People's Choice Award
HYLN Investors Have Opportunity to Lead Hyliion Holdings Corp. Securities Fraud Lawsuit
HYLN Investors Have Opportunity to Lead Hyliion Holdings Corp. Securities Fraud Lawsuit
1 MONTH INVESTOR DEADLINE: UWM Holdings Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit Before October 13, 2026 Deadline, Robbins Geller Rudman & Dowd LLP Announces - UWMC
1 MONTH INVESTOR DEADLINE: UWM Holdings Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit Before October 13, 2026 Deadline, Robbins Geller Rudman & Dowd LLP Announces - UWMC
Insurance Agent Nick Hogan Explains What First-Time Homeowners Often Miss About Homeowners Insurance in HelloNation
Insurance Agent Nick Hogan Explains What First-Time Homeowners Often Miss About Homeowners Insurance in HelloNation
REGN INVESTOR DEADLINE TOMORROW: Regeneron Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit, Robbins Geller Rudman & Dowd LLP Announces
REGN INVESTOR DEADLINE TOMORROW: Regeneron Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit, Robbins Geller Rudman & Dowd LLP Announces
GORGIE INTRODUCES BERRY BURST, BRINGING BOLD BERRY FLAVOR AND IT-GIRL STYLE TO MODERN ENERGY
GORGIE INTRODUCES BERRY BURST, BRINGING BOLD BERRY FLAVOR AND IT-GIRL STYLE TO MODERN ENERGY
Phase III TAISHAN-302 Trial Shows Tam-Peli Significantly Improves Survival in Relapsed Small-Cell Lung Cancer
Phase III TAISHAN-302 Trial Shows Tam-Peli Significantly Improves Survival in Relapsed Small-Cell Lung Cancer
Phase III MAVERICK Trial Supports Brain MRI Surveillance Alone as Standard of Care for Small-Cell Lung Cancer
Phase III MAVERICK Trial Supports Brain MRI Surveillance Alone as Standard of Care for Small-Cell Lung Cancer
Rackspace Technology Deadline: RXT Investors Have Opportunity to Lead Rackspace Technology, Inc. Securities Fraud Lawsuit
Rackspace Technology Deadline: RXT Investors Have Opportunity to Lead Rackspace Technology, Inc. Securities Fraud Lawsuit
GAC AION UT gewinnt den Preis für das beste Außendesign beim Torino Automotive Design Award 2026
GAC AION UT gewinnt den Preis für das beste Außendesign beim Torino Automotive Design Award 2026
L'AION UT de GAC remporte le prix du meilleur design extérieur lors du Torino Automotive Design Award 2026
L'AION UT de GAC remporte le prix du meilleur design extérieur lors du Torino Automotive Design Award 2026
Sacituzumab Govitecan Plus Pembrolizumab Does Not Meet Primary Endpoints in First-Line PD-L1-High Metastatic NSCLC
Sacituzumab Govitecan Plus Pembrolizumab Does Not Meet Primary Endpoints in First-Line PD-L1-High Metastatic NSCLC
Desktop versie